Literature DB >> 3942958

The correlation between the radiologic staging studies and histopathologic findings in aggressive stage 3 giant cell tumor of bone.

D Present, F Bertoni, T Hudson, W F Enneking.   

Abstract

The histologic features of aggressive Stage 3 benign giant cell tumor of bone were correlated with their radiologic staging studies. Our series includes 24 patients treated at the University of Florida, Department of Orthopaedic Oncology, from January 1979 to July 1983. Particularly in 13 cases, results of routine specimen histologic as well as of the histologic study of macrosections containing the entire resected specimen (the tumor and surrounding bone and soft tissue) were evaluated. Surgical staging studies including plain radiographs, bone scintigrams, computerized axial tomography scans, tomography, and angiography were used to delineate the anatomic location of the lesion. Within this group of giant cell tumors, the general histologic features resemble those of the classic giant cell tumor. However, certain aggressive features best demonstrated on the macrosections, such as cortical and subchondral invasion, capsular and reactive bony zone infiltration, "digital extension" of the tumor, and neovascularity correlated well with the anatomic localization and aggressiveness found on the staging studies. Those findings emphasize the value of staging studies in the delineation of the histologic potential of these benign aggressive lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3942958     DOI: 10.1002/1097-0142(19860115)57:2<237::aid-cncr2820570209>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Case report 757: Giant cell tumor of rib.

Authors:  R M Hanna; M Kyriakos; S F Quinn
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Oncolytic adenovirus Ad11 enhances the chemotherapy effect of cisplatin on osteosarcoma cells by inhibiting autophagy.

Authors:  Bin Zhang; Yan Zhang; Rongzhen Li; Jiazhen Li; Xinchang Lu; Yi Zhang
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

3.  Giant-cell tumor of bone, stage II, displaying translocation t(12;19)(q13;q13).

Authors:  R Noguera; A Llombart-Bosch; C Lopez-Gines; C Carda; C Fernandez
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Histological and clinical characteristics of malignant giant cell tumor of bone.

Authors:  Lihua Gong; Weifeng Liu; Xiaoqi Sun; Constantin Sajdik; Xinxia Tian; Xiaohui Niu; Xiaoyuan Huang
Journal:  Virchows Arch       Date:  2012-02-17       Impact factor: 4.064

5.  Giant cell tumor in children and adolescents.

Authors:  H E Schütte; W K Taconis
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

6.  Telomere reduction in giant cell tumor of bone and with aging.

Authors:  H S Schwartz; G A Dahir; M G Butler
Journal:  Cancer Genet Cytogenet       Date:  1993-12

7.  Retrospective Audit of Various Surgical Modalities Adopted for Giant Cell Tumor in a Rural Tertiary Cancer Center.

Authors:  Basavaraj Ankalkoti; B Satheesan; J Dipin; P Nizamudheen; N Sangeetha
Journal:  Indian J Surg Oncol       Date:  2019-05-06

8.  [Ewing's sarcoma, fibrogenic tumors, giant cell tumor, hemangioma of bone : Radiology and pathology].

Authors:  J Freyschmidt; H Ostertag
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

9.  [Humeral localization of a recurrent giant cell tumor (about one case)].

Authors:  Youssef Nader; Issam Serghini; Idrissi Khalid Koulali; Hicham Salahi; Farid Galwia
Journal:  Pan Afr Med J       Date:  2015-01-05

10.  The value of large sections in surgical pathology.

Authors:  Maria P Foschini; Chiara Baldovini; Yuko Ishikawa; Vincenzo Eusebi
Journal:  Int J Breast Cancer       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.